Dnah9 mutant mice and organoid models recapitulate the clinical features of patients with PCD and provide an excellent platform for drug screening.

MLA

Zheng, Rui, et al. “Dnah9 Mutant Mice and Organoid Models Recapitulate the Clinical Features of Patients with PCD and Provide an Excellent Platform for Drug Screening.” Cell Death & Disease, vol. 13, no. 6, June 2022, p. 559. EBSCOhost, https://doi.org/10.1038/s41419-022-05010-5.

APA

Zheng, R., Yang, W., Wen, Y., Xie, L., Shi, F., Lu, D., Luo, J., Li, Y., Zhang, R., Chen, T., Chen, L., Xu, W., & Liu, H. (2022). Dnah9 mutant mice and organoid models recapitulate the clinical features of patients with PCD and provide an excellent platform for drug screening. Cell Death & Disease, 13(6), 559. https://doi.org/10.1038/s41419-022-05010-5

Chicago

Zheng, Rui, Wenhao Yang, Yuting Wen, Liang Xie, Fang Shi, Danli Lu, Jiaxin Luo, et al. 2022. “Dnah9 Mutant Mice and Organoid Models Recapitulate the Clinical Features of Patients with PCD and Provide an Excellent Platform for Drug Screening.” Cell Death & Disease 13 (6): 559. doi:10.1038/s41419-022-05010-5.